文献速递病毒性肝炎艾滋病与性传播感染

注射吸毒者丙肝病毒传播、复发与再感染的系统发育分析

A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.
PubMed 文献 · J Infect Dis · 2020-01-01

该研究对纽约布朗克斯3家阿片类激动剂治疗诊所的150名注射吸毒者进行HCV高变区1二代测序,以区分再感染与治疗失败并识别传播关联。结果发现3对传播关联,均来自同一诊所且涉及配偶或同居伴侣;9人未获持续病毒学应答,4人获SVR后再度出现病毒血症,其中2例为不同毒株再感染。

要点

  • 二代测序可帮助区分HCV再感染与复发。
  • 传播关联集中于同一诊所的配偶或同居伴侣。
  • 获得SVR后仍需关注持续风险行为者的病毒血症。

核心结论

  • 二代测序是识别HCV传播并区分复发与再感染的重要工具。
  • 结果强调需对伴侣及SVR后仍有风险行为者加强减少伤害干预。

研究设计与样本

  • 分析纽约布朗克斯3家OAT诊所150名PWID的基线与随访标本。
  • 对HCV高变区1行二代测序,并用Global Hepatitis Outbreak and Surveillance Technology分析。

主要发现

  • 研究参与者间存在3个传播关联。
  • 9人未获SVR:7人随访序列与基线相似,2人死亡。
  • 4人获SVR后随访病毒血症:2例再感染不同毒株,1例晚期治疗失败,1例治疗后17个月短暂病毒血症。
  • 所有传播关联均来自同一OAT诊所,涉及配偶或同居伴侣。

临床怎么用

  • 对PWID可考虑用二代测序区分HCV复发与再感染。
  • 对配偶或同居伴侣及SVR后仍有风险行为者加强减少伤害干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is essential for HCV elimination. We aimed to differentiate reinfections from treatment failures and to identify transmission linkages and associated factors in a cohort of PWID receiving opioid agonist therapy (OAT). METHODS: We analyzed baseline and follow-up specimens from 150 PWID from 3 OAT clinics in the Bronx, New York. Next-generation sequencing data from the hypervariable region 1 of HCV were analyzed using Global Hepatitis Outbreak and Surveillance Technology. RESULTS: There were 3 transmission linkages between study participants. Sustained virologic response (SVR) was not achieved in 9 participants: 7 had follow-up specimens with similar sequences to baseline, and 2 died. In 4 additional participants, SVR was achieved but the participants were viremic at later follow-up: 2 were reinfected with different strains, 1 had a late treatment failure, and 1 was transiently viremic 17 months after treatment. All transmission linkages were from the same OAT clinic and involved spousal or common-law partnerships. CONCLUSION: This study highlights the use of next-generation sequencing as an important tool for identifying viral transmission and to help distinguish relapse and reinfection among PWID. Results reinforce the need for harm reduction interventions among couples and those who report ongoing risk factors after SVR.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Akiyama MJ, Lipsey D, Ganova-Raeva L, et al. A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy. J Infect Dis. 2020. PMID: 32150621. doi:10.1093/infdis/jiaa100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。